It’s always nice to be recognized. Being called one of the “Fabulous Four” Bay Area businesses by a leading business columnist? Even better.
San Jose Mercury News writer Chris O’Brien recently featured Navigenics in his write-up of Bay Area companies that are succeeding during this global economic downturn. His profile is a pleasant acknowledgement of all the hard work that has gone into creating the genetic testing service that is most recommended by physicians.
He noted that Navigenics’ genetic tests enable people to determine whether they have a genetic predisposition for a variety of diseases, including colon cancer and multiple sclerosis. With this genetic insight, people can then take action, making changes to prevent the conditions, delay their onset, or get earlier diagnosis and treatment.
“Navigenics is a big step toward the promise of more personalized medicine,” he wrote. “And it’s the kind of innovation only now possible thanks to the mapping of the human genome and other genetic research.”
We believe that we can fundamentally improve health outcomes across the population by empowering people to act based on an understanding of their genetic predisposition for certain medical conditions. We have one very basic mission—to help you live healthier, longer.
It’s nice that concept is being publicly recognized.